Position in STRO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$12,937,774
+$8,668,550 QoQ
Shares Held
389,692
+127.4% QoQ
Ownership
2.35%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 97 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in STRO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,764,044 across 520 Biotechnology names. STRO ranks #170 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in STRO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,937,774 | 389,692 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $4,269,224 | 171,386 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $971,636 | 83,979 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $714,223 | 820,948 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $580,008 | 816,915 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $1,228,026 | 1,889,272 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,411,390 | 1,854,017 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $6,425,066 | 1,856,956 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $5,054,076 | 1,724,941 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $7,267,685 | 1,286,316 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $5,402,126 | 1,259,237 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,154,117 | 1,197,152 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $5,401,123 | 1,161,532 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,880,170 | 1,056,314 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $8,250,318 | 1,021,079 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,721,645 | 850,747 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,245,050 | 814,789 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $6,483,903 | 788,796 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $11,065,943 | 743,679 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $13,071,426 | 691,976 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $12,598,554 | 677,706 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $12,896,931 | 566,649 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $9,086,047 | 418,519 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $3,220,864 | 320,484 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,035,618 | 262,322 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,218,420 | 119,453 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||